Iridina Antibiotico (Tobramycin)

Tobramycin targets bacterial ribosomes by binding to the 30S subunit, causing misreading of messenger RNA. This interferes with protein synthesis, leading to bacterial cell death, especially against gram‑negative organisms that commonly cause external ear infections.

The dosage and duration of Iridina Antibiotico are determined by the prescribing clinician based on the severity of the infection, patient age, and ear condition. Healthcare professionals will provide specific instructions on how many drops to instill and how often.

Safety data for topical tobramycin during pregnancy and lactation are limited. Prescribers weigh potential benefits against risks and may avoid use unless the infection is severe and no safer alternative is available.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Iridina Antibiotico (tobramycin) belongs to the aminoglycoside class, offering strong activity against gram‑negative bacteria. Alternatives such as ciprofloxacin or ofloxacin are fluoroquinolones with a broader spectrum but different safety profiles. Choice depends on bacterial susceptibility, patient tolerance, and clinician preference.

Store the product at room temperature, ideally below 25 °C. Keep the container tightly closed, protect it from moisture and direct light, and do not freeze. Follow any additional handling instructions on the label to maintain product stability.

The medication is applied directly into the affected ear. The prescriber will advise the number of drops per dose and the frequency, typically after gently cleaning the ear canal. The patient should lie with the treated ear facing upward for a few minutes to ensure proper distribution.

Serious risks include ototoxicity, which can lead to hearing loss or balance problems, especially with prolonged use or when combined with other ototoxic agents. Systemic absorption may rarely cause kidney toxicity, and severe allergic reactions such as rash, swelling, or anaphylaxis require immediate medical attention.

Patients with a known hypersensitivity to tobramycin or other aminoglycosides should avoid the product. It is also contraindicated in individuals with a perforated tympanic membrane unless specifically directed by a physician, and caution is advised for those with significant renal impairment.